Be carefulMonth ago Liminal announced the acquisition of scientifics assets from the biotech Fairhaven.
In fact this business was owned by ken Galbraith and Garry Bridger, CEO and board member of Liminal. Over and above the money they personaly earned the purpose of the transaction was a $3 millionsd cross financing.
It's fun to see what they are willing to do for some bucks...
This long awaiting filing is-it the conclusion of a very well prepared documentation or an other emergency solution to wake up the market and trying to find some money.
Today they are out of cash. They only have SALP credit margin (if still available) to continue running.
Should we trust them? Time will tell.